Other languages Aclarion, Inc.

Equities

ACON

US6551872012

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-22 EDT			5-day change	1st Jan Change
0.334 ^USD	+7.74%		+20.14%	-89.56%

02-26	Top Midday Decliners	MT
02-21	Aclarion, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Top Midday Decliners	02-26
Aclarion, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-21
Top Premarket Decliners	02-02
Wall Street Set to Open Marginally Lower Friday; December Inflation Data Lower Than Forecast	01-26
US Futures Nudge Lower in Friday's Premarket Ahead of Fed Inflation Data	01-26
Wall Street Set to Open Flat as Investors Eye Key Manufacturing Index	01-23
Aclarion Announces Updated Product Release That Expands Mri Scanner Access for Nociscan Solution	01-17
Top Midday Gainers	01-08
Aclarion and Atec Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan	01-08
Aclarion to Implement 1-for-16 Reverse Stock Split; Shares Rise	01-02
Aclarion, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14
Aclarion to Form Partnership With Alphatec Holdings Unit to Accelerate Marketing of Nociscan	23-10-23
Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan	23-10-23
Aclarion, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-25
Aclarion, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-07-03
Aclarion Signs Commercial Deal With Michigan Medical Imaging Center	23-06-14
Aclarion, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27
Aclarion, Inc. Auditor Raises 'Going Concern' Doubt	23-02-26
Aclarion, Inc. George Frey MD as Key Opinion Leader	23-01-17
Aclarion, Inc’s Key Opinion Leader Program Adds Fifth Surgeon Advisor with Addition of Eric Potts, MD	22-12-21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Aclarion, Inc.

Equities

ACON

US6551872012

Other languages

Filters